TEICOPLANIN SANDOZ teicoplanin 400mg powder for injection vial with diluent ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

teicoplanin sandoz teicoplanin 400mg powder for injection vial with diluent ampoule

sandoz pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium chloride - teicoplanin sandoz is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (non-cardiac bacteraemia, septicaemia).

Teicoplanin 200 mg powder and solvent for solution for injection/infusion or oral solution Malta - English - Medicines Authority

teicoplanin 200 mg powder and solvent for solution for injection/infusion or oral solution

ibigen s.r.l via fossignano, 2, 04011 aprilia (lt), italy - teicoplanin - powder and solvent for solution for infusion or injection oral solution - teicoplanin 200 mg - antibacterials for systemic use

Teicoplanine Altan Pharma 200 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teicoplanine altan pharma 200 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp.

altan pharma ltd. - teicoplanin 200 mg - powder and solvent for solution for injection/infusion; powder and solvent for oral solution - 200 mg - teicoplanin 200 mg - teicoplanin

Teicoplanin Bradex 200 mg inj./inf. sol. (pwdr. + solv.)/or. sol. i.v./i.m. vial + amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teicoplanin bradex 200 mg inj./inf. sol. (pwdr. + solv.)/or. sol. i.v./i.m. vial + amp.

bradex s.a. - teicoplanin 200 mg - powder and solvent for solution for injection/infusion; oral solution - 200 mg - teicoplanin 200 mg - teicoplanin

Targocid 200 mg i.m./i.v. vial + amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

targocid 200 mg i.m./i.v. vial + amp.

sanofi belgium sa-nv - teicoplanin 200 mg - powder and solvent for oral solution/for solution for injection/infusion - 200 mg - teicoplanin 200 mg - teicoplanin

Teicoplanin 200 mg Powder and Solvent for Solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 200 mg powder and solvent for solution for injection/infusion or oral solution

noridem enterprises limited - teicoplanin - powder and solvent for solution for injection/infusion - 200 milligram(s) - glycopeptide antibacterials; teicoplanin - glycopeptide antibacterials - it is indicated in adults and in children from birth for the parenteral treatment of the following infections :  complicated skin and soft tissue infections,  bone and joint infections,  hospital acquired pneumonia,  community acquired pneumonia,  complicated urinary tract infections,  infective endocarditis,  peritonitis associated with continuous ambulatory peritoneal dialysis (capd)  bacteraemia that occurs in association with any of the indications listed above.

Teicoplanin 200mg Powder and Solvent for solution for injection/infusion or oral solution Ireland - English - HPRA (Health Products Regulatory Authority)

teicoplanin 200mg powder and solvent for solution for injection/infusion or oral solution

rowex ltd - teicoplanin - powder and solvent for solution for injection/infusion - 200 milligram(s) - glycopeptide antibacterials; teicoplanin - : glycopeptide antibacterials - complicated skin and soft tissue infections, bone and joint infections, hospital acquired pneumonia, community acquired pneumonia, complicated urinary tract infections, infective endocarditis, peritonitis associated with continuous ambulatory peritoneal dialysis (capd), bacteraemia that occurs in association with any of the indications listed above

TARGOCID 200mg POWDER FOR SOLUTION FOR INJECTIONINFUSION Singapore - English - HSA (Health Sciences Authority)

targocid 200mg powder for solution for injectioninfusion

sanofi-aventis singapore pte. ltd. - teicoplanin - injection, powder, for solution - 200 mg/vial - teicoplanin 200 mg/vial

Targocid New Zealand - English - Medsafe (Medicines Safety Authority)

targocid

sanofi-aventis new zealand limited - teicoplanin 200mg;   - powder for injection with diluent - 200 mg - active: teicoplanin 200mg   excipient: sodium chloride sodium hydroxide water for injection

TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

teicoplanin sxp teicoplanin 400 mg powder for injection with diluent ampoule

southern cross pharma pty ltd - teicoplanin, quantity: 400 mg - injection, powder for - excipient ingredients: sodium hydroxide; sodium chloride - teicoplanin is indicated for the treatment of the following serious infections due to staphylococci or streptococci, which cannot be treated satisfactorily with less toxic agents, including beta-lactam antibiotics: bone (osteomyelitis); joints (septic arthritis); blood (noncardiac bacteraemia, septicaemia).